These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 789413

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dosage titration with furosemide in congestive heart failure patients.
    Exaire JE, Villalpando J, Hamdan G, Figueroa G.
    Angiology; 1975 Oct; 26(9):665-70. PubMed ID: 1053607
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
    Paterna S, Parrinello G, Cannizzaro S, Fasullo S, Torres D, Sarullo FM, Di Pasquale P.
    Am J Cardiol; 2009 Jan 01; 103(1):93-102. PubMed ID: 19101237
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of furosemide oral solution versus furosemide tablets on diuresis and electrolytes in patients with moderate congestive heart failure.
    Cohen N, Golik A, Dishi V, Zaidenstein R, Weissgarten J, Averbukh Z, Modai D.
    Miner Electrolyte Metab; 1996 Jan 01; 22(4):248-52. PubMed ID: 8807629
    [Abstract] [Full Text] [Related]

  • 10. A fixed-dose combination of furosemide and spironolactone in digitalized congestive heart failure patients.
    Yasky J, Ledesma GA, Tutera A, Collia LF.
    Pharmatherapeutica; 1986 Jan 01; 4(8):473-9. PubMed ID: 3714755
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
    Cotter G, Weissgarten J, Metzkor E, Moshkovitz Y, Litinski I, Tavori U, Perry C, Zaidenstein R, Golik A.
    Clin Pharmacol Ther; 1997 Aug 01; 62(2):187-93. PubMed ID: 9284855
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Steady state absorption kinetics and pharmacodynamics of furosemide in congestive heart failure.
    Chaturvedi PR, O'Donnell JP, Nicholas JM, Shoenthal DR, Waters DH, Gwilt PR.
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar 01; 25(3):123-8. PubMed ID: 3557737
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Diuretic effects of subcutaneous furosemide in human volunteers: a randomized pilot study.
    Verma AK, da Silva JH, Kuhl DR.
    Ann Pharmacother; 2004 Apr 01; 38(4):544-9. PubMed ID: 14982985
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Experiences with high doses of furosemide in renal disease and resistant edematous states.
    Silverberg DS, Ulan RA, Baltzan MA, Baltzan RB.
    Can Med Assoc J; 1970 Jul 18; 103(2):129-33. PubMed ID: 5430050
    [Abstract] [Full Text] [Related]

  • 19. [Body fluid withdrawal with isolated ultrafiltration effects persistent improvement of functional capacity in patients with chronic congestive heart failure. Furosemide does not produce the same result].
    Marenzi G, Guazzi M, Lauri G, Perego GB, Sganzerla P, Agostoni P.
    Cardiologia; 1994 Nov 18; 39(11):763-72. PubMed ID: 7736475
    [Abstract] [Full Text] [Related]

  • 20. [Evaluation of the effect of nifedipine in patients with chronic congestive heart failure].
    Cholewa M, Górski L, Gawor Z, Markiewicz K, Dryjański T, Bechler-Lisińska J, Broks-Bratkowska B.
    Kardiol Pol; 1989 Nov 18; 32 Suppl 2():33-40. PubMed ID: 2699339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.